Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verastem, Inc.(VSTM) | 3,349,627 | 3,042,775 | -306,852 | $12.80M | $24.49M | 20.45% | +$11.70M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 1,389,622 | 2,786,249 | +1,396,627 | $6.07M | $11.26M | 9.40% | +$5.18M |
| Evolus, Inc.(EOLS) | 1,590,162 | 971,622 | -618,540 | $11.04M | $7.77M | 6.49% | -$3.26M |
| Adma Biologics Inc | 740,000 | 700,000 | -40,000 | $6.19M | $7.02M | 5.86% | +$827.2K |
| Nektar Therapeutics(NKTR) | 120,654 | 110,000 | -10,654 | $8.42M | $6.66M | 5.56% | -$1.76M |
| Eloxx Pharmaceuticals Inc | 397,160 | 381,977 | -15,183 | $5.51M | $5.85M | 4.88% | +$335.5K |
| Satellos Bioscience Inc.(MSLE) | 491,624 | 455,058 | -36,566 | $3.72M | $3.87M | 3.23% | +$143.0K |
| Kazia Therapeutics LimitedADS(KZIA) | 345,179 | 377,429 | +32,250 | $4.86M | $3.62M | 3.02% | -$1.24M |
| Indivior Pharmaceuticals Inc(INDV) | 100,000 | 100,000 | 0 | $4.10M | $3.58M | 2.99% | -$518.0K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 25,000 | 210,000 | +185,000 | $834.8K | $3.16M | 2.64% | +$2.32M |
| Edesa Biotech, Inc.(EDSA) | 456,439 | 710,266 | +253,827 | $3.19M | $2.99M | 2.50% | -$200.6K |
| Boston Scientific Corporation(BSX) | 0 | 55,000 | +55,000 | $0 | $2.40M | 2.00% | +$2.40M |
| Aytu Biopharma Inc | 912,921 | 964,900 | +51,979 | $1.96M | $2.06M | 1.72% | +$102.1K |
| An2 Therapeutics Inc | 551,692 | 350,877 | -200,815 | $2.67M | $1.87M | 1.56% | -$803.5K |
| Xilio Therapeutics, Inc.(XLO) | 225,994 | 189,092 | -36,902 | $2.17M | $1.71M | 1.43% | -$453.7K |
| Pyxis Oncology, Inc.(PYXS) | 0 | 689,000 | +689,000 | $0 | $1.61M | 1.34% | +$1.61M |
| Abeona Therapeutics Inc.(ABEO) | 557,284 | 282,016 | -275,268 | $3.44M | $1.48M | 1.24% | -$1.96M |
| Surrozen, Inc.(SRZN) | 0 | 44,100 | +44,100 | $0 | $1.42M | 1.18% | +$1.42M |
| Cellectar Biosciences, Inc.(CLRB) | 104,550 | 749,028 | +644,478 | $290.6K | $1.38M | 1.15% | +$1.09M |
| Pasithea Therapeutics Corp.(KTTA) | 2,201,468 | 2,774,234 | +572,766 | $1.13M | $1.37M | 1.14% | +$233.1K |
| Adicet Bio Inc | 245,518 | 188,201 | -57,317 | $2.12M | $1.34M | 1.12% | -$777.5K |
| Inhibikase Therapeutics, Inc.(IKT) | 396,179 | 647,285 | +251,106 | $804.2K | $1.33M | 1.11% | +$525.9K |
| OKYO Pharma LimitedSHS NEW(OKYO) | 862,996 | 914,367 | +51,371 | $1.29M | $1.18M | 0.98% | -$115.0K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 199,486 | 252,434 | +52,948 | $965.5K | $1.15M | 0.96% | +$185.6K |
| Tenax Therapeutics, Inc.(TENX) | 660,000 | 588,000 | -72,000 | $9.60M | $1.11M | 0.93% | -$8.49M |
| Zevra Therapeutics, Inc.(ZVRA) | 258,701 | 100,000 | -158,701 | $3.71M | $1.10M | 0.92% | -$2.61M |
| Cabaletta Bio, Inc.(CABA) | 917,100 | 520,000 | -397,100 | $2.85M | $998.4K | 0.83% | -$1.85M |
| Codexis, Inc.(CDXS) | 109,662 | 676,973 | +567,311 | $247.8K | $941.0K | 0.79% | +$693.2K |
| In8bio Inc | 695,287 | 697,852 | +2,565 | $980.4K | $928.1K | 0.77% | -$52.2K |
| Gossamer Bio Inc | 0 | 63,039 | +63,039 | $0 | $747.0K | 0.62% | +$747.0K |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 20,000 | +20,000 | $0 | $743.8K | 0.62% | +$743.8K |
| Azitra, Inc.(AZTR) | 5,285,476 | 5,227,438 | -58,038 | $886.9K | $719.3K | 0.60% | -$167.6K |
| Femasys Inc | 0 | 326,770 | +326,770 | $0 | $705.8K | 0.59% | +$705.8K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 161,583 | 254,759 | +93,176 | $783.7K | $705.7K | 0.59% | -$78.0K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 50,000 | 60,000 | +10,000 | $973.5K | $702.0K | 0.59% | -$271.5K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 425,000 | 95,000 | -330,000 | $3.99M | $647.9K | 0.54% | -$3.34M |
| AEON Biopharma, Inc.CL A(AEON) | 0 | 2,125,748 | +2,125,748 | $0 | $637.7K | 0.53% | +$637.7K |
| Alumis Inc | 0 | 85,000 | +85,000 | $0 | $628.1K | 0.52% | +$628.1K |
| CytomX Therapeutics, Inc.(CTMX) | 205,000 | 220,000 | +15,000 | $768.8K | $598.4K | 0.50% | -$170.3K |
| Sintx Technologies, Inc.(SINT) | 209,205 | 233,936 | +24,731 | $332.5K | $521.7K | 0.44% | +$189.1K |
| Zai Lab LimitedADR(ZLAB) | 0 | 18,998 | +18,998 | $0 | $500.4K | 0.42% | +$500.4K |
| Opus Genetics, Inc.(IRD) | 100,718 | 98,147 | -2,571 | $414.0K | $475.0K | 0.40% | +$61.1K |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 787,269 | +787,269 | $0 | $469.4K | 0.39% | +$469.4K |
| Calcimedica Inc | 0 | 278,680 | +278,680 | $0 | $451.5K | 0.38% | +$451.5K |
| Pliant Therapeutics, Inc.(PLRX) | 230,538 | 414,903 | +184,365 | $262.8K | $448.1K | 0.37% | +$185.3K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 130,684 | 162,818 | +32,134 | $595.9K | $443.7K | 0.37% | -$152.2K |
| X4 Pharmaceuticals, Inc.(XFOR) | 224,989 | 150,000 | -74,989 | $1.05M | $435.0K | 0.36% | -$615.7K |
| NervGen Pharma Corp.(NGEN) | 271,678 | 200,000 | -71,678 | $559.7K | $382.0K | 0.32% | -$177.7K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 43,491 | 40,000 | -3,491 | $287.5K | $364.0K | 0.30% | +$76.5K |
| SAB Biotherapeutics, Inc.(SABS) | 73,271 | 88,108 | +14,837 | $285.8K | $279.3K | 0.23% | -$6.5K |
| ImageneBio, Inc.(IMA) | 0 | 57,663 | +57,663 | $0 | $264.1K | 0.22% | +$264.1K |
| Q32 Bio Inc.(QTTB) | 0 | 31,200 | +31,200 | $0 | $258.0K | 0.22% | +$258.0K |
| QT Imaging Holdings, Inc.(QTI) | 100,000 | 100,000 | 0 | $407.0K | $254.5K | 0.21% | -$152.5K |
| MaxCyte, Inc.(MXCT) | 751,606 | 224,881 | -526,725 | $924.5K | $251.9K | 0.21% | -$672.6K |
| CNS Pharmaceuticals, Inc.(CNSP) | 41,573 | 39,942 | -1,631 | $198.7K | $211.7K | 0.18% | +$13.0K |
| Pulmonx Corporation(LUNG) | 815,436 | 110,479 | -704,957 | $1.06M | $211.0K | 0.18% | -$849.1K |
| EyePoint, Inc.(EYPT) | 0 | 55,000 | +55,000 | $0 | $179.8K | 0.15% | +$179.8K |
| Ardelyx Inc | 0 | 51,000 | +51,000 | $0 | $174.4K | 0.15% | +$174.4K |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 20,000 | +20,000 | $0 | $153.4K | 0.13% | +$153.4K |
| Boundless Bio, Inc.(BOLD) | 154,595 | 52,547 | -102,048 | $386.5K | $131.9K | 0.11% | -$254.6K |
| Climb Bio, Inc.(CLYM) | 0 | 10,000 | +10,000 | $0 | $114.7K | 0.10% | +$114.7K |
| Kalaris Therapeutics, Inc.(KLRS) | 30,122 | 33,842 | +3,720 | $122.6K | $97.8K | 0.08% | -$24.8K |
| BioAge Labs, Inc.(BIOA) | 20,000 | 11,948 | -8,052 | $490.2K | $84.7K | 0.07% | -$405.5K |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 364,254 | 49,468 | -314,786 | $866.9K | $54.4K | 0.05% | -$812.5K |
| Evaxion A/SADS(EVAX) | 17,562 | 16,566 | -996 | $54.4K | $54.3K | 0.05% | -$106 |
| Geron Corporation(GERN) | 0 | 20,000 | +20,000 | $0 | $24.6K | 0.02% | +$24.6K |
| Adlai Nortye Group Ltd.ADS(ANL) | 24,257 | 0 | -24,257 | $279.0K | $0 | — | -$279.0K |
| Arvinas, Inc.(ARVN) | 60,000 | 0 | -60,000 | $498.6K | $0 | — | -$498.6K |
| BioAtla, Inc.(BCAB) | 16,432 | 0 | -16,432 | $68.0K | $0 | — | -$68.0K |
| CalciMedica, Inc.(CALC) | 622,432 | 0 | -622,432 | $544.9K | $0 | — | -$544.9K |
| Compugen Ltd.(CGEN) | 31,387 | 0 | -31,387 | $67.2K | $0 | — | -$67.2K |
| Crescent Biopharma, Inc.(CBIO) | 40,000 | 0 | -40,000 | $720.0K | $0 | — | -$720.0K |
| Curis, Inc.(CRIS) | 3,312,185 | 0 | -3,312,185 | $1.73M | $0 | — | -$1.73M |
| Helus Pharma Inc(HELP) | 129,280 | 0 | -129,280 | $854.5K | $0 | — | -$854.5K |
| Heron Therapeutics, Inc.(HRTX) | 490,787 | 0 | -490,787 | $209.5K | $0 | — | -$209.5K |
| Humacyte, Inc.(HUMA) | 231,299 | 0 | -231,299 | $180.5K | $0 | — | -$180.5K |
| Nuvectis Pharma, Inc.(NVCT) | 40,000 | 0 | -40,000 | $735.6K | $0 | — | -$735.6K |
| Oruka Therapeutics, Inc.(ORKA) | 7,500 | 0 | -7,500 | $713.8K | $0 | — | -$713.8K |
| Ovid Therapeutics Inc.(OVID) | 21,300 | 0 | -21,300 | $57.3K | $0 | — | -$57.3K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 85,010 | 0 | -85,010 | $922.4K | $0 | — | -$922.4K |
| PMV Pharmaceuticals, Inc.(PMVP) | 536,086 | 0 | -536,086 | $718.4K | $0 | — | -$718.4K |
| Precision Optics Corporation, Inc.(POCI) | 46,390 | 0 | -46,390 | $236.6K | $0 | — | -$236.6K |
| Processa Pharmaceuticals, Inc.(PCSA) | 55,000 | 0 | -55,000 | $105.6K | $0 | — | -$105.6K |
| Radiopharm Theranostics LimitedADS(RADX) | 51,000,000 | 0 | -51,000,000 | $670.5K | $0 | — | -$670.5K |
| Rein Therapeutics Inc.(RNTX) | 218,038 | 0 | -218,038 | $226.8K | $0 | — | -$226.8K |
| Senseonics Holdings, Inc.(SENS) | 48,680 | 0 | -48,680 | $276.5K | $0 | — | -$276.5K |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 14,469 | 0 | -14,469 | $1.07M | $0 | — | -$1.07M |
| Spruce Biosciences Inc | 28,795 | 0 | -28,795 | $1.55M | $0 | — | -$1.55M |
| TELA Bio, Inc.(TELA) | 2,662,427 | 0 | -2,662,427 | $2.00M | $0 | — | -$2.00M |
| Upstream Bio, Inc.(UPB) | 33,432 | 0 | -33,432 | $231.3K | $0 | — | -$231.3K |